AI Verdict
ABBV has stronger fundamentals based on our AI analysis.
ABBV vs EW Fundamental Comparison
| Metric | ABBV | EW |
|---|---|---|
| Revenue | $15.0B | $1.6B |
| Net Income | $695.0M | $380.7M |
| Net Margin | 4.6% | 23.1% |
| ROE | N/A | 3.7% |
| ROA | 0.5% | 2.9% |
| Current Ratio | 0.80x | 4.42x |
| Debt/Equity | N/A | 0.06x |
| EPS | $0.39 | $0.66 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs EW: Frequently Asked Questions
Is ABBV or EW the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABBV has stronger fundamentals. ABBV is graded C (78% confidence) while EW is graded C (76% confidence). This is not investment advice.
How does ABBV compare to EW fundamentally?
AbbVie Inc. has ROE of N/A vs Edwards Lifesciences Corp's 3.7%. Net margins are 4.6% vs 23.1% respectively.
Which stock pays higher dividends, ABBV or EW?
ABBV has a dividend yield of N/A or no dividend while EW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or EW for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while EW has a C grade with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs EW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs EW, the AI consensus favors ABBV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.